Literature DB >> 24410704

Cyclobenzaprine: a new look at an old pharmacological agent.

Nevio Cimolai1.   

Abstract

Cyclobenzaprine is a tricyclic pharmacologic agent that has enjoyed considerable use since its availability. Most clinical usages have focused on the muscle relaxant properties, the mechanism of action being more recently redefined. Higher orders of the CNS are, nevertheless, affected, and the latter contributes to the spectrum of proclaimed side effects that are otherwise largely anticholinergic in nature. Cyclobenzaprine has a reasonable safety profile and overdoses are not as problematic as those for accepted tricyclic psychotherapeutic agents. Clinical studies have given supportive, albeit not conclusive, evidence for treatment roles in the short-term management of acute neck and back pain, and fibromyalgia. Further and more exacting science is warranted to explore the value of this drug in other neurological and psychiatric contexts.

Entities:  

Year:  2009        PMID: 24410704     DOI: 10.1586/ecp.09.5

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  3 in total

1.  Cyclo-benzaprinium salicylate.

Authors:  Hoong-Kun Fun; Chin Sing Yeap; M S Siddegowda; H S Yathirajan; B Narayana
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-04

2.  Cyclo-benzaprinium chloride.

Authors:  M S Siddegowda; Jerry P Jasinski; James A Golen; H S Yathirajan; M T Swamy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-30

3.  [3-(5-Hy-droxy-5H-dibenzo[a,d]cyclo-hepten-5-yl)prop-yl]dimethyl-ammonium 3-carboxyprop-2-enoate.

Authors:  Jerry P Jasinski; James A Golen; M S Siddegowda; H S Yathirajan; B Narayana
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.